CNBC's Annika Kim Constantino joins 'Closing Bell Overtime' to talk changes coming out of the CDC and FDA.
Breakdown
- FDA may approve drugs based on one well-designed clinical trial
- Change could speed up approvals for drugs treating large populations 39s
- Viking Therapeutics' stock rose up to 13% after the announcement 10s
- Uncertainty remains for drugs with ongoing phase three trials 1m 22s
- Policy could help companies commercialize drugs independently 1m 46s